Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular

S Hamasaki1, J Al Suwaidi, S T Higano

  • 1Center for Coronary Physiology and Imaging, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.

Insights

Hypertension with left ventricular hypertrophy (LVH) is linked to coronary vascular remodeling and reduced coronary flow reserve. This impacts endothelial function, highlighting the need for further cardiovascular research.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Hypertension Research

Background:

  • The relationship between coronary vascular remodeling, endothelial function, and hypertension with left ventricular hypertrophy (LVH) remains incompletely understood.
  • Investigating coronary flow reserve in patients with hypertension and LVH is crucial for understanding cardiovascular disease progression.

Purpose of the Study:

  • To determine the association between hypertension and left ventricular hypertrophy (LVH) with coronary vascular remodeling.
  • To evaluate the impact of hypertension and LVH on endothelial function and coronary flow reserve.

Main Methods:

  • Intravascular ultrasound was used to assess coronary artery dimensions in 111 patients.
  • Patients were categorized into three groups: hypertensive with LVH, hypertensive without LVH, and normotensive.
  • Vascular reactivity was assessed using intracoronary infusions of adenosine and acetylcholine.

Main Results:

  • Patients with LVH exhibited significantly greater coronary vessel area compared to hypertensive patients without LVH.
  • Coronary blood flow was significantly higher at baseline in patients with LVH.
  • Endothelial and nonendothelial responses to acetylcholine and adenosine were significantly impaired in patients with LVH.

Conclusions:

  • Hypertension combined with left ventricular hypertrophy is associated with significant coronary vascular remodeling.
  • Patients with hypertension and LVH demonstrate attenuated endothelial and nonendothelial coronary flow reserve.
  • These findings underscore the detrimental effects of hypertension and LVH on coronary vascular health.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...